Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proyecto de Biomedicina CIMA (PBC) serves as the commercial and technology transfer vehicle for the Center for Applied Medical Research (CIMA) at the University of Navarra in Spain. The company is responsible for managing the intellectual property portfolio generated by CIMA's extensive research programs and facilitating the translation of these discoveries into clinical development. PBC operates through a unique public-private partnership model, establishing strategic alliances with global pharmaceutical companies and launching specialized spin-off biotechs. Its primary therapeutic focus areas include oncology, hepatology, cardiovascular diseases, and neuroscience. By bridging the gap between academic research and the healthcare industry, PBC has successfully advanced several candidates, including gene therapies and small molecules, into human clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proyecto de Biomedicina CIMA.